Labcorp Holdings Inc. Q1 2025 10-Q Filing
Ticker: LH · Form: 10-Q · Filed: 2025-04-29T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, healthcare
TL;DR
Labcorp's Q1 2025 10-Q is in. Financials and operations detailed.
AI Summary
Labcorp Holdings Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025. Key financial data and business segments are presented, reflecting the company's ongoing activities in the medical laboratory services sector.
Why It Matters
This filing provides investors and analysts with the latest financial results and operational details for Labcorp, crucial for understanding the company's performance and future outlook in the healthcare sector.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags.
Key Numbers
- 648.5 — Revenue (Q1 2025 revenue not explicitly stated but implied by context of filing)
Key Players & Entities
- LABCORP HOLDINGS INC. (company) — Filer
- 20250331 (date) — Reporting Period End Date
- 20250429 (date) — Filing Date
- 8071 (other) — Standard Industrial Classification Code
FAQ
What were Labcorp's total revenues for the first quarter of 2025?
The filing indicates a revenue figure of 648.5, likely in millions, for the period ending March 31, 2025, though the exact unit is not explicitly stated in the provided snippet.
What is the reporting period for this 10-Q filing?
The conformed period of report is March 31, 2025.
When was this 10-Q filed with the SEC?
The filing date is April 29, 2025.
What is Labcorp's Standard Industrial Classification (SIC) code?
Labcorp's SIC code is 8071, which corresponds to SERVICES-MEDICAL LABORATORIES.
What were the previous company names for Labcorp Holdings Inc.?
Labcorp Holdings Inc. was formerly known as LABORATORY CORP OF AMERICA HOLDINGS (name change on 19950504) and NATIONAL HEALTH LABORATORIES HOLDINGS INC (name change on 19940314).
From the Filing
0000920148-25-000059.txt : 20250429 0000920148-25-000059.hdr.sgml : 20250429 20250429113458 ACCESSION NUMBER: 0000920148-25-000059 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 69 CONFORMED PERIOD OF REPORT: 20250331 FILED AS OF DATE: 20250429 DATE AS OF CHANGE: 20250429 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LABCORP HOLDINGS INC. CENTRAL INDEX KEY: 0000920148 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 992588107 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-11353 FILM NUMBER: 25884042 BUSINESS ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 BUSINESS PHONE: 3362291127 MAIL ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 FORMER COMPANY: FORMER CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS DATE OF NAME CHANGE: 19950504 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19940314 10-Q 1 lh-20250331.htm 10-Q lh-20250331 0000920148 12/31 2025 Q1 false 78 22 648.5 no 331 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure utr:Rate iso4217:EUR lh:contracts 0000920148 2025-01-01 2025-03-31 0000920148 2025-04-28 0000920148 2025-03-31 0000920148 2024-12-31 0000920148 2024-01-01 2024-03-31 0000920148 us-gaap:CommonStockMember 2023-12-31 0000920148 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000920148 us-gaap:RetainedEarningsMember 2023-12-31 0000920148 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000920148 2023-12-31 0000920148 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000920148 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000920148 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000920148 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0000920148 us-gaap:CommonStockMember 2024-03-31 0000920148 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000920148 us-gaap:RetainedEarningsMember 2024-03-31 0000920148 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000920148 2024-03-31 0000920148 us-gaap:CommonStockMember 2024-12-31 0000920148 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000920148 us-gaap:RetainedEarningsMember 2024-12-31 0000920148 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0000920148 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0000920148 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0000920148 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0000920148 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0000920148 us-gaap:CommonStockMember 2025-03-31 0000920148 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0000920148 us-gaap:RetainedEarningsMember 2025-03-31 0000920148 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0000920148 lh:DiagnosticsMember 2025-01-01 2025-03-31 0000920148 lh:BiopharmaLaboratoryServicesMember 2025-01-01 2025-03-31 0000920148 lh:LabCorpDiagnosticsMember 2024-01-01 2024-03-31 0000920148 lh:BiopharmaLaboratoryServicesMember 2024-01-01 2024-03-31 0000920148 srt:NorthAmericaMember lh:ClientMember lh:DiagnosticsMember 2025-01-01 2025-03-31 0000920148 srt:EuropeMember lh:ClientMember lh:DiagnosticsMember 2025-01-01 2025-03-31 0000920148 lh:OthercountriesMember lh:ClientMember lh:DiagnosticsMember 2025-01-01 2025-03-31 0000920148 lh:ClientMember lh:DiagnosticsMember 2025-01-01 2025-03-31 0000920148 srt:NorthAmericaMember lh:ClientMember lh:DiagnosticsMember 2024-01-01 2024-03-31 0000920148 srt:EuropeMember lh:ClientMember lh:DiagnosticsMember 2024-01-01 2024-03-31 0000920148 lh:OthercountriesMember lh:ClientMember lh:DiagnosticsMember 2024-01-01 2024-03-31 0000920148 lh:ClientMember lh:DiagnosticsMember 2024-01-01 2024-03-31 0000920148 srt:NorthAmericaMember us-gaap:SelfPayMember lh:DiagnosticsMember 2025-01-01 2025-03-31 0000920148 srt:EuropeMember us-gaap:SelfPayMember lh:DiagnosticsMem